Chinese General Practice ›› 2024, Vol. 27 ›› Issue (23): 2913-2920.DOI: 10.12114/j.issn.1007-9572.2023.0660
Special Issue: 消化系统疾病最新文章合辑
• Evidence-based Medicine • Previous Articles Next Articles
Received:
2023-08-15
Revised:
2024-03-03
Published:
2024-08-15
Online:
2024-05-08
Contact:
FU Wenjun
通讯作者:
富文俊
作者简介:
作者贡献:
王婷提出主要研究目标,负责研究的构思与设计,研究的实施,撰写论文;王婷、王海燕进行数据的收集与整理,统计学处理,图、表的绘制与展示;王海燕、富文俊进行论文的修订;富文俊负责文章的质量控制与审查,对文章整体负责,监督管理。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0660
第一作者 | 发表时间(年) | 样本量(例) | 年龄(岁) | 性别(女/男) | 干预措施 | 剂量(次/周) | 疗程(周) | 结局指标 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
对照组 | 观察组 | 对照组 | 观察组 | 对照组 | 观察组 | 对照组 | 观察组 | 对照组 | 观察组 | 对照组 | 观察组 | |||
蒋韬[ | 2022 | 40 | 40 | 常规西药 | 西药+电针 | 21 | 14 | 2 | 2 | ① | ||||
曹雯[ | 2021 | 47 | 48 | 常规西药 | 西药+隔姜灸 | 14 | 6 | 4 | 4 | ① | ||||
任妙[ | 2021 | 30 | 30 | 46.25±5.31 | 47.18±5.49 | 17/13 | 16/14 | 常规西药 | 西药+火龙灸 | 14 | 16 | 4 | 4 | ① |
韩晓江[ | 2020 | 67 | 67 | 52±7 | 51±8 | 30/37 | 27/40 | 常规西药 | 西药+针刺 | 14 | 17 | 2 | 2 | ① |
肖慈信[ | 2020 | 31 | 31 | 42.58±0.26 | 43.25±0.29 | 常规西药 | 针刺 | 7 | 6 | 4 | 4 | ① | ||
洪东逍[ | 2020 | 37 | 37 | 49.21±4.25 | 49.21±4.25 | 常规西药 | 温针灸 | 14 | 7 | 8 | 8 | ①②③ | ||
王建[ | 2019 | 40 | 40 | 35.12±1.35 | 34.36±0.99 | 17/23 | 18/22 | 常规西药 | 西药+针刺 | 21 | 28 | 4 | 4 | ① |
周新桃[ | 2019 | 50 | 50 | 45.36±5.18 | 44.86±5.07 | 22/28 | 24/26 | 常规西药 | 雷火灸 | 21 | 7 | 2 | 2 | ① |
杨娜[ | 2017 | 30 | 30 | 46.83±11.04 | 46.83±10.76 | 17/13 | 16/14 | 常规西药 | 针刺 | 14 | 5 | 4 | 4 | ① |
王荟清[ | 2018 | 25 | 25 | 46.28±1.31 | 45.96±1.54 | 11/14 | 12/13 | 常规西药 | 西药+针刺 | 21 | 26 | 8 | 8 | ① |
徐旋[ | 2018 | 32 | 32 | 51.2±10.9 | 51.3±10.0 | 13/19 | 15/17 | 常规西药 | 针刺 | 14 | 5 | 12 | 12 | ①② |
李崖雪[ | 2016 | 30 | 30 | 常规西药 | 西药+针刺 | 21 | 27 | 12 | 12 | ① | ||||
张勇[ | 2016 | 53 | 53 | 54.26±1.65 | 52.32±1.75 | 25/28 | 24/29 | 常规西药 | 针刺 | 21 | 5 | 6 | 6 | ② |
官春[ | 2016 | 30 | 30 | 常规西药 | 西药+穴位注射 | 21 | 24 | 8 | 8 | ①② | ||||
温又霖[ | 2015 | 36 | 38 | 50.73±11.20 | 50.63±12.50 | 14/16 | 13/17 | 常规西药 | 温针灸 | 21 | 3 | 12 | 12 | ①②③ |
高淼[ | 2015 | 23 | 22 | 38.92±5.56 | 39.41±5.87 | 8/15 | 8/14 | 常规西药 | 温针灸 | 14 | 7 | 8 | 8 | ① |
景卫政[ | 2015 | 28 | 28 | 47.54±7.15 | 47.59±7.14 | 13/15 | 12/16 | 常规西药 | 针刺 | 14 | 7 | 8 | 8 | ① |
李国徽[ | 2014 | 45 | 65 | 常规西药 | 穴位埋线 | 21 | 0.5 | 24 | 24 | ①②③ | ||||
隋翠翠[ | 2014 | 28 | 28 | 常规西药 | 西药+针刺 | 14 | 21 | 4 | 4 | ①② | ||||
贾剑南[ | 2013 | 61 | 61 | 50.6±11.1 | 52.1±12.6 | 31/30 | 30/31 | 常规西药 | 西药+针刺 | 21 | 28 | 8 | 8 | ①②③ |
牛桦[ | 2012 | 30 | 30 | 48±12 | 45±12 | 12/18 | 15/15 | 常规西药 | 穴位埋线 | 21 | 1 | 24 | 24 | ① |
金晓飞[ | 2010 | 40 | 40 | 16/24 | 22/18 | 常规西药 | 针刺 | 14 | 6 | 4 | 4 | ② | ||
英健民[ | 2009 | 45 | 45 | 常规西药 | 温针灸 | 21 | 7 | 12 | 12 | ①②③ | ||||
谷巍[ | 2009 | 40 | 40 | 47.68±8.53 | 48.30±8.75 | 18/22 | 17/23 | 常规西药 | 温针灸 | 14 | 7 | 8 | 8 | ①②③ |
杨瑞春[ | 2008 | 45 | 45 | 常规西药 | 温针灸 | 21 | 7 | 12 | 12 | ①②③ | ||||
陈菲[ | 2008 | 30 | 30 | 54.24±7.59 | 53.87±10.12 | 13/17 | 10/20 | 常规西药 | 西药+穴位注射 | 21 | 3 | 8 | 8 | ①②③ |
Table 1 Basic characteristics of included studies
第一作者 | 发表时间(年) | 样本量(例) | 年龄(岁) | 性别(女/男) | 干预措施 | 剂量(次/周) | 疗程(周) | 结局指标 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
对照组 | 观察组 | 对照组 | 观察组 | 对照组 | 观察组 | 对照组 | 观察组 | 对照组 | 观察组 | 对照组 | 观察组 | |||
蒋韬[ | 2022 | 40 | 40 | 常规西药 | 西药+电针 | 21 | 14 | 2 | 2 | ① | ||||
曹雯[ | 2021 | 47 | 48 | 常规西药 | 西药+隔姜灸 | 14 | 6 | 4 | 4 | ① | ||||
任妙[ | 2021 | 30 | 30 | 46.25±5.31 | 47.18±5.49 | 17/13 | 16/14 | 常规西药 | 西药+火龙灸 | 14 | 16 | 4 | 4 | ① |
韩晓江[ | 2020 | 67 | 67 | 52±7 | 51±8 | 30/37 | 27/40 | 常规西药 | 西药+针刺 | 14 | 17 | 2 | 2 | ① |
肖慈信[ | 2020 | 31 | 31 | 42.58±0.26 | 43.25±0.29 | 常规西药 | 针刺 | 7 | 6 | 4 | 4 | ① | ||
洪东逍[ | 2020 | 37 | 37 | 49.21±4.25 | 49.21±4.25 | 常规西药 | 温针灸 | 14 | 7 | 8 | 8 | ①②③ | ||
王建[ | 2019 | 40 | 40 | 35.12±1.35 | 34.36±0.99 | 17/23 | 18/22 | 常规西药 | 西药+针刺 | 21 | 28 | 4 | 4 | ① |
周新桃[ | 2019 | 50 | 50 | 45.36±5.18 | 44.86±5.07 | 22/28 | 24/26 | 常规西药 | 雷火灸 | 21 | 7 | 2 | 2 | ① |
杨娜[ | 2017 | 30 | 30 | 46.83±11.04 | 46.83±10.76 | 17/13 | 16/14 | 常规西药 | 针刺 | 14 | 5 | 4 | 4 | ① |
王荟清[ | 2018 | 25 | 25 | 46.28±1.31 | 45.96±1.54 | 11/14 | 12/13 | 常规西药 | 西药+针刺 | 21 | 26 | 8 | 8 | ① |
徐旋[ | 2018 | 32 | 32 | 51.2±10.9 | 51.3±10.0 | 13/19 | 15/17 | 常规西药 | 针刺 | 14 | 5 | 12 | 12 | ①② |
李崖雪[ | 2016 | 30 | 30 | 常规西药 | 西药+针刺 | 21 | 27 | 12 | 12 | ① | ||||
张勇[ | 2016 | 53 | 53 | 54.26±1.65 | 52.32±1.75 | 25/28 | 24/29 | 常规西药 | 针刺 | 21 | 5 | 6 | 6 | ② |
官春[ | 2016 | 30 | 30 | 常规西药 | 西药+穴位注射 | 21 | 24 | 8 | 8 | ①② | ||||
温又霖[ | 2015 | 36 | 38 | 50.73±11.20 | 50.63±12.50 | 14/16 | 13/17 | 常规西药 | 温针灸 | 21 | 3 | 12 | 12 | ①②③ |
高淼[ | 2015 | 23 | 22 | 38.92±5.56 | 39.41±5.87 | 8/15 | 8/14 | 常规西药 | 温针灸 | 14 | 7 | 8 | 8 | ① |
景卫政[ | 2015 | 28 | 28 | 47.54±7.15 | 47.59±7.14 | 13/15 | 12/16 | 常规西药 | 针刺 | 14 | 7 | 8 | 8 | ① |
李国徽[ | 2014 | 45 | 65 | 常规西药 | 穴位埋线 | 21 | 0.5 | 24 | 24 | ①②③ | ||||
隋翠翠[ | 2014 | 28 | 28 | 常规西药 | 西药+针刺 | 14 | 21 | 4 | 4 | ①② | ||||
贾剑南[ | 2013 | 61 | 61 | 50.6±11.1 | 52.1±12.6 | 31/30 | 30/31 | 常规西药 | 西药+针刺 | 21 | 28 | 8 | 8 | ①②③ |
牛桦[ | 2012 | 30 | 30 | 48±12 | 45±12 | 12/18 | 15/15 | 常规西药 | 穴位埋线 | 21 | 1 | 24 | 24 | ① |
金晓飞[ | 2010 | 40 | 40 | 16/24 | 22/18 | 常规西药 | 针刺 | 14 | 6 | 4 | 4 | ② | ||
英健民[ | 2009 | 45 | 45 | 常规西药 | 温针灸 | 21 | 7 | 12 | 12 | ①②③ | ||||
谷巍[ | 2009 | 40 | 40 | 47.68±8.53 | 48.30±8.75 | 18/22 | 17/23 | 常规西药 | 温针灸 | 14 | 7 | 8 | 8 | ①②③ |
杨瑞春[ | 2008 | 45 | 45 | 常规西药 | 温针灸 | 21 | 7 | 12 | 12 | ①②③ | ||||
陈菲[ | 2008 | 30 | 30 | 54.24±7.59 | 53.87±10.12 | 13/17 | 10/20 | 常规西药 | 西药+穴位注射 | 21 | 3 | 8 | 8 | ①②③ |
干预措施 | A | B | C | D | E | F | G | H | I |
---|---|---|---|---|---|---|---|---|---|
B | 0.93(0.74~1.15) | ||||||||
C | 1.13(0.81~1.57) | 1.22(0.88~1.70) | |||||||
D | 0.88(0.68~1.12) | 0.95(0.73~1.22) | 0.78(0.55~1.11) | ||||||
E | 0.96(0.78~1.17) | 1.03(0.85~1.27) | 0.85(0.62~1.17) | 1.09(0.87~1.37) | |||||
F | 1.08(0.83~1.39) | 1.16(0.90~1.51) | 0.96(0.67~1.36) | 1.23(0.93~1.62) | 1.13(0.89~1.43) | ||||
G | 0.96(0.69~1.30) | 1.03(0.74~1.40) | 0.85(0.56~1.25) | 1.09(0.77~1.51) | 1.00(0.73~1.33) | 0.89(0.62~1.23) | |||
H | 1.04(0.77~1.39) | 1.12(0.84~1.51) | 0.92(0.63~1.34) | 1.19(0.86~1.61) | 1.08(0.82~1.43) | 0.96(0.70~1.32) | 1.09(0.76~1.60) | ||
I | 0.84(0.63~1.10) | 0.90(0.68~1.20) | 0.74(0.51~1.08) | 0.96(0.70~1.30) | 0.88(0.67~1.13) | 0.78(0.56~1.06) | 0.88(0.61~1.27) | 0.81(0.57~1.13) | |
J | 1.20(1.04~1.41)a | 1.30(1.11~1.54)a | 1.07(0.80~1.44) | 1.37(1.14~1.69)a | 1.25(1.12~1.43)a | 1.11(0.92~1.38) | 1.26(0.98~1.70) | 1.16(0.91~1.49) | 1.43(1.15~1.85)a |
Table 2 Clinical efficacy of acupuncture in the treatment of CAG network meta-analysis results
干预措施 | A | B | C | D | E | F | G | H | I |
---|---|---|---|---|---|---|---|---|---|
B | 0.93(0.74~1.15) | ||||||||
C | 1.13(0.81~1.57) | 1.22(0.88~1.70) | |||||||
D | 0.88(0.68~1.12) | 0.95(0.73~1.22) | 0.78(0.55~1.11) | ||||||
E | 0.96(0.78~1.17) | 1.03(0.85~1.27) | 0.85(0.62~1.17) | 1.09(0.87~1.37) | |||||
F | 1.08(0.83~1.39) | 1.16(0.90~1.51) | 0.96(0.67~1.36) | 1.23(0.93~1.62) | 1.13(0.89~1.43) | ||||
G | 0.96(0.69~1.30) | 1.03(0.74~1.40) | 0.85(0.56~1.25) | 1.09(0.77~1.51) | 1.00(0.73~1.33) | 0.89(0.62~1.23) | |||
H | 1.04(0.77~1.39) | 1.12(0.84~1.51) | 0.92(0.63~1.34) | 1.19(0.86~1.61) | 1.08(0.82~1.43) | 0.96(0.70~1.32) | 1.09(0.76~1.60) | ||
I | 0.84(0.63~1.10) | 0.90(0.68~1.20) | 0.74(0.51~1.08) | 0.96(0.70~1.30) | 0.88(0.67~1.13) | 0.78(0.56~1.06) | 0.88(0.61~1.27) | 0.81(0.57~1.13) | |
J | 1.20(1.04~1.41)a | 1.30(1.11~1.54)a | 1.07(0.80~1.44) | 1.37(1.14~1.69)a | 1.25(1.12~1.43)a | 1.11(0.92~1.38) | 1.26(0.98~1.70) | 1.16(0.91~1.49) | 1.43(1.15~1.85)a |
干预措施 | A | B | D | E | I |
---|---|---|---|---|---|
B | 0.97(0.74~1.27) | ||||
D | 0.87(0.61~1.22) | 0.89(0.61~1.29) | |||
E | 0.92(0.74~1.15) | 0.95(0.74~1.23) | 1.06(0.77~1.51) | ||
I | 1.03(0.79~1.33) | 1.06(0.78~1.41) | 1.19(0.83~1.72) | 1.12(0.86~1.43) | |
J | 1.25(1.08~1.49)a | 1.29(1.05~1.61)a | 1.45(1.09~2.00)a | 1.36(1.19~1.58)a | 1.22(1.01~1.52)a |
Table 3 Gastroscopy efficacy of acupuncture in the treatment of CAG network meta-analysis results
干预措施 | A | B | D | E | I |
---|---|---|---|---|---|
B | 0.97(0.74~1.27) | ||||
D | 0.87(0.61~1.22) | 0.89(0.61~1.29) | |||
E | 0.92(0.74~1.15) | 0.95(0.74~1.23) | 1.06(0.77~1.51) | ||
I | 1.03(0.79~1.33) | 1.06(0.78~1.41) | 1.19(0.83~1.72) | 1.12(0.86~1.43) | |
J | 1.25(1.08~1.49)a | 1.29(1.05~1.61)a | 1.45(1.09~2.00)a | 1.36(1.19~1.58)a | 1.22(1.01~1.52)a |
干预措施 | A | B | D | E | I |
---|---|---|---|---|---|
B | 0.96(0.51~1.84) | ||||
D | 0.84(0.45~1.60) | 0.88(0.49~1.58) | |||
E | 0.99(0.59~1.70) | 1.04(0.66~1.66) | 1.18(0.76~1.88) | ||
I | 1.00(0.53~1.93) | 1.05(0.58~1.88) | 1.20(0.67~2.15) | 1.01(0.64~1.58) | |
J | 1.29(0.80~2.16) | 1.35(0.89~2.08) | 1.54(1.03~2.38)a | 1.31(1.09~1.59)a | 1.29(0.87~1.97) |
Table 4 Pathological efficacy of acupuncture in the treatment of CAG network meta-analysis results
干预措施 | A | B | D | E | I |
---|---|---|---|---|---|
B | 0.96(0.51~1.84) | ||||
D | 0.84(0.45~1.60) | 0.88(0.49~1.58) | |||
E | 0.99(0.59~1.70) | 1.04(0.66~1.66) | 1.18(0.76~1.88) | ||
I | 1.00(0.53~1.93) | 1.05(0.58~1.88) | 1.20(0.67~2.15) | 1.01(0.64~1.58) | |
J | 1.29(0.80~2.16) | 1.35(0.89~2.08) | 1.54(1.03~2.38)a | 1.31(1.09~1.59)a | 1.29(0.87~1.97) |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
李军祥,陈誩,吕宾,等. 慢性萎缩性胃炎中西医结合诊疗共识意见(2017年)[J]. 中国中西医结合消化杂志,2018,26(2):121-131.
|
[6] |
|
[7] |
|
[8] |
李璇,陈婷,李敬华,等. 基于中医药循证文献大数据平台的慢性萎缩性胃炎临床证据图研究[J]. 中医杂志,2023,64(8):790-798. DOI:10.13288/j.11-2166/r.2023.08.008.
|
[9] |
李知行,张海华,王丹萍,等. 针灸治疗慢性萎缩性胃炎的作用机制研究进展[J]. 中国针灸,2016,36(10):1117-1120. DOI:10.13703/j.0255-2930.2016.10.035.
|
[10] |
于中麟. 慢性胃炎的内镜分型分级标准及治疗的试行意见[J]. 中华消化内镜杂志,2004,21(2):4-5.
|
[11] |
房静远,刘文忠,李兆申,等. 中国慢性胃炎共识意见[J]. 胃肠病学,2013,18(1):24-36.
|
[12] |
林三仁,于中麟,胡品津,等. 全国慢性胃炎研讨会共识意见[J]. 现代实用医学,2004,16(4):245-247.
|
[13] |
|
[14] |
蒋韬,王振国,闫海洋,等. 电针联合幽门螺旋杆菌根除治疗在慢性萎缩性胃炎治疗中的效果评价[J]. 新疆中医药,2022,40(4):30-31.
|
[15] |
曹雯,张靖娟,林晨辉,等. 隔姜灸治疗慢性萎缩性胃炎的临床研究[J]. 上海针灸杂志,2021,40(8):950-953. DOI:10.13460/j.issn.1005-0957.2021.08.0950.
|
[16] | |
[17] |
韩晓江,杜锦辉,毕连宝,等. 胃三针联合PPI三联疗法治疗幽门螺杆菌阳性慢性萎缩性胃炎疗效观察[J]. 上海针灸杂志,2020,39(1):11-14. DOI:10.13460/j.issn.1005-0957.2020.01.0011.
|
[18] |
肖慈信. 针灸治疗慢性萎缩性胃炎疗效对比分析 [J]. 养生保健指南,2020(25):262-263.
|
[19] |
洪东逍. 针灸治疗慢性萎缩性胃炎疗效对比观察分析[J]. 养生保健指南,2020(36):86.
|
[20] |
周新桃,严芳琴. 恒温雷火灸联合健康指导干预慢性萎缩性胃炎的疗效分析[J]. 实用中医内科杂志,2019,33(12):64-67. DOI:10.13729/j.issn.1671-7813.z20190504.
|
[21] | |
[22] |
徐旋. "金钩钓鱼"针法针刺华佗夹脊穴治疗慢性萎缩性胃炎的临床研究[D]. 兰州:甘肃中医药大学,2018.
|
[23] |
王荟清,许可可,戴明. 脾胃老十针治疗慢性萎缩性胃炎伴肠上皮化生的临床效果[J]. 中国医药导报,2018,15(33):106-109.
|
[24] |
杨娜. 针刺背俞穴治疗慢性萎缩性胃炎的临床观察及T淋巴细胞亚群的研究[D]. 咸阳:陕西中医药大学,2017.
|
[25] |
官春,刘少庭,李向波,等. 丹参注射液足三里穴位注射治疗慢性萎缩性胃炎的临床研究[J]. 世界最新医学信息文摘(连续型电子期刊),2016,16(10):23. DOI:10.3969/j.issn.1671-3141.2016.10.011.
|
[26] |
张勇,薛志欣,胡薇. 针刺治疗慢性萎缩性胃炎合并幽门螺杆菌感染疗效观察[J]. 陕西中医,2016,37(8):1078-1079. DOI:10.3969/j.issn.1000-7369.2016.08.066.
|
[27] |
李崖雪,李晓陵,张帆,等. 原络通经针法配合药物治疗慢性萎缩性胃炎(脾胃亏虚型)的疗效[J]. 中国老年学杂志,2016,36(15):3751-3752. DOI:10.3969/j.issn.1005-9202.2016.15.065.
|
[28] | |
[29] | |
[30] | |
[31] | |
[32] | |
[33] | |
[34] | |
[35] |
谷巍,胡起超. 针灸治疗慢性萎缩性胃炎疗效对比观察[J]. 中国针灸,2009,29(5):361-364.
|
[36] |
陈菲. 黄芪注射液穴位注射治疗慢性萎缩性胃炎的临床研究[D]. 咸阳:陕西中医学院,2008.
|
[37] | |
[38] |
温又霖. 温针灸背俞穴对脾胃虚弱型萎缩性胃炎临床疗效的影响[D]. 南京:南京中医药大学,2015.
|
[39] |
牛桦,李涛,何晓华,等. 穴位埋线治疗慢性萎缩性胃炎的临床观察[J]. 宁夏医学杂志,2012,34(11):1178-1180. DOI:10.13621/j.1001-5949.2012.11.009.
|
[40] |
朱永钦,朱永苹,黄连梅,等. 慢性萎缩性胃炎中医病因病机和辨证分型的临床研究进展[J]. 中华中医药学刊,2017,35(2):322-325. DOI:10.13193/j.issn.1673-7717.2017.02.018.
|
[41] |
丁鑫,袁方,王毅,等. 基于脾虚毒损胃络探讨慢性萎缩性胃炎的病机及论治[J]. 时珍国医国药,2023,34(1):142-144. DOI:10.3969/j.issn.1008-0805.2023.01.37.
|
[42] | |
[43] | |
[44] |
王坤,马林,汪花,等. 穴位埋线对慢性萎缩性胃炎大鼠JAK 2-STAT 3信号转导通路相关因子表达的影响[J]. 针刺研究,2018,43(11):682-686. DOI:10.13702/j.1000-0607.180178.
|
[45] |
马林,章小梅,黄德裕. 穴位埋线对慢性萎缩性胃炎大鼠胃黏膜形态及血清SOD、MDA含量的影响[J]. 广州中医药大学学报,2020,37(5):910-914. DOI:10.13359/j.cnki.gzxbtcm.2020.05.023.
|
[46] |
郭卫中,李彩君,王坤,等. 针药结合治疗慢性萎缩性胃炎Meta分析[J]. 中医学报,2019,34(8):1797-1804. DOI:10.16368/j.issn.1674-8999.2019.08.422.
|
[47] |
薛茸丹,周炜,刘雅萍,等. 针灸治疗慢性萎缩性胃炎的Meta分析[J]. 医学综述,2020,26(15):3097-3106. DOI:10.3969/j.issn.1006-2084.2020.15.035.
|
[1] | QUAN Jialin, ZHU Lin, SU Yu, CHEN Zekai, CHEN Ziqi, ZHANG Zhuofan. Research on the Improvement Effect of Exercise Modes on the Executive Function of Overweight or Obese Children or Adolescents: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(27): 3422-3431. |
[2] | LI Hao, LI Jiangtao, LIU Dan, WANG Jianjun. Efficacy and Safety of Belimumab, Anifrolumab, and Telitacicept on the Treatment of Systemic Lupus Erythematosus: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(23): 2924-2933. |
[3] | MA Panpan, WANG Sijing, YOU Na, DING Dafa, LU Yibing. Efficacy and Safety of Danuglipron and Orforglipron in the Treatment of Type 2 Diabetes Mellitus: a Meta-analysis [J]. Chinese General Practice, 2025, 28(21): 2679-2685. |
[4] | ADILI Tuersun, CHENG Gang. Meta-analysis of the Efficacy and Safety of Finerenone in the Treatment of Type 2 Diabetic Nephropathy [J]. Chinese General Practice, 2025, 28(21): 2686-2691. |
[5] | ZHU Shengjie, DIAO Huaqiong, HANG Xiaoyi, SUN Wenjun. Network Meta-analysis of Different Traditional Chinese Medicine Injections for the Treatment of Posterior Circulatory Ischemic Vertigo [J]. Chinese General Practice, 2025, 28(14): 1795-1808. |
[6] | CHI Xun, LIU Sisi, CHEN Qiao, HU Yue, WANG Weixian. The Suitability of Four Nutritional Screening Tools for Nutritional Screening in Patients with Cirrhosis: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(11): 1395-1402. |
[7] | GU Mingyu, QIN Tingting, QIAO Kun, BAI Xinyuan, WANG Yao, YANG Yutong, LI Xingming. A Network Meta-analysis of Primary Hypertension Management Patterns in China [J]. Chinese General Practice, 2025, 28(10): 1265-1272. |
[8] | SONG Fenfen, LI Shengmian. Real-World Study of Camrelizumab-based Regimen for Locally Advanced and Metastatic Esophageal Cancer [J]. Chinese General Practice, 2025, 28(07): 844-852. |
[9] | GUO Jia, CAO Chunmei, LIU Guochun, ZHENG Man, ZHU Ruihan, LONG Wei. Effects of Different Exercise Types on Sleep in Insomnia Patients: a Network Meta-analysis [J]. Chinese General Practice, 2024, 27(35): 4376-4387. |
[10] | LI Shirui, ZHANG Zhenxiang, WANG Wenna, ZHANG Jie, ZHAO Zhixin. The Influence of Environmental Factors on Self-efficacy in the Community Stroke Patients [J]. Chinese General Practice, 2024, 27(28): 3535-3539. |
[11] | HUANG Tengjia, CAO Xi, CHEN Lei, LI Ziying, QIN Lihua. The Effectiveness of Non-pharmacological Treatment for Post-stroke Shoulder-hand Syndrome: a Network Meta-analysis [J]. Chinese General Practice, 2024, 27(23): 2921-2930. |
[12] | WU Kairui, YE Yu, LI Jiaoyue, PEI Bei, LI Xuejun, CHENG Hongliang. A Multicenter Randomized Controlled Clinical Trial Study on the Effect of Piwei Peiyuan Decoction Combined with Acupuncture in the Treatment of Chronic Atrophic Gastritis with Intestinal Metaplasia [J]. Chinese General Practice, 2024, 27(20): 2466-2475. |
[13] | TAN Shufa, ZHANG Leichang, GAO Qiangqiang, OU Yan, HUANG Shuilan. Efficacy and Safety of Biologics and Small Molecule Drugs in the Treatment of Ulcerative Colitis: a Network Meta-analysis [J]. Chinese General Practice, 2024, 27(17): 2155-2166. |
[14] | YANG Lihong, ZHANG Chao, LI Zefang, YANG Chen, WANG Fei, DU Yuzheng, SHI Huiyan. A Case Registry Study of Acupuncture Treatment for Stroke: Data Elements and Definitions [J]. Chinese General Practice, 2024, 27(16): 2023-2032. |
[15] | NIU Jingyuan, CHEN Huisheng, YU Jiaxiang, CUI Yu. Ligustrazine Injection in the Treatment of Acute Ischemic Stroke: a Bayesian Network Meta-analysis [J]. Chinese General Practice, 2024, 27(14): 1761-1774. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||